头颈内分泌手术围手术期疼痛管理与阿片类药物减量:美国头颈学会内分泌外科分会共识声明
该共识由美国头颈学会内分泌外科分会专家小组制定,针对甲状腺和甲状旁腺手术的围手术期疼痛管理,通过广泛文献回顾和改良德尔菲调查形成推荐,旨在提供基于证据的术后疼痛管理方案并限制不必要的阿片类药物使用。
要点
- 甲状腺和甲状旁腺手术术后疼痛管理应基于证据,减少不必要的阿片类药物使用。
- 共识推荐基于专家小组文献回顾和改良德尔菲调查形成。
- 重点在于限制阿片类药物过度使用,以应对成瘾危机。
核心结论
- 该专家共识为头颈内分泌手术术后疼痛管理提供了基于证据的推荐,重点在于限制不必要的阿片类镇痛药使用。
研究设计与样本
- 由美国头颈学会及其内分泌外科分会和ThyCa成员组成专家小组,进行广泛文献回顾,构建推荐条目,并采用改良德尔菲调查评估组内共识。
临床怎么用
- 临床可参考该共识进行甲状腺和甲状旁腺手术的围手术期疼痛管理,以减少不必要的阿片类药物使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This American Head and Neck Society (AHNS) consensus statement focuses on evidence-based comprehensive pain management practices for thyroid and parathyroid surgery. Overutilization of opioids for postoperative pain management is a major contributing factor to the opioid addiction epidemic however evidence-based guidelines for pain management after routine head and neck endocrine procedures are lacking. METHODS: An expert panel was convened from the membership of the AHNS, its Endocrine Surgical Section, and ThyCa. An extensive literature review was performed, and recommendations addressing several pain management subtopics were constructed based on best available evidence. A modified Delphi survey was then utilized to evaluate group consensus of these statements. CONCLUSIONS: This expert consensus provides evidence-based recommendations for effective postoperative pain management following head and neck endocrine procedures with a focus on limiting unnecessary use of opioid analgesics.
引用
- Ferrell JK, Shindo ML, Stack BC, et al. Perioperative pain management and opioid-reduction in head and neck endocrine surgery: An American Head and Neck Society Endocrine Surgery Section consensus statement. Head Neck. 2021. PMID: 34080732. doi:10.1002/hed.26774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。